Rossari Biotech eyes Rp7bn from 2020 listing
Indian chemical manufacturer Rossari Biotech has filed draft documents for an IPO, which it is planning to launch in the first quarter next year, according to a source close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts